Pimelic 2-aminobenzamide HDAC-inhibitors were found to most effectively induce frataxin expression by increasing acetylation at lysine residues in histones 3 and 4 within intron 1 in human cell and animal FA models [72, 118]. Here, FXN is linked to Friedreich ataxia.